Search
for
Sort by
Research 61–90 of 332
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação
- Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia
- GLP‐1 agonists and hair loss: a call for further investigation
- A Systematic Review of the Cutaneous Adverse Effects of GLP-1 Agonists
- Hair and Scalp Effects of GLP-1 Receptor Agonists in Practice
- Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study
- Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin
- Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications
- Peptide Therapy in Aesthetic, Metabolic, and Endocrine Medicine
- EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS
- THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Endocrinologia e Medicina Estética Ed. X
- Semaglutide and the Skin: An Overview of Current Evidence
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Exploring the role of two polypeptide nanofiber gels derived from RADA16-I self-assembly in accelerating burn wound healing
- Abstracts from the 2024 WDS Forum - virtual option